Skip to main content
OpenTrials
Completed

NCT Number: NCT01593618

Empowering Cancer Survivors Through Information Technology

This is a randomized controlled trial of a web-based informational intervention (UMFollowUp) for adolescent and young adult survivors of childhood cancer to improve cancer knowledge and psychosocial functioning.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cancer Survivor

Age range

15 year–28 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Masonic Cancer Center, University of Minnesota

Minneapolis, Minnesota, 55455, United States

About this study

Individuals randomly assigned to the control group will receive standard of care for the duration of their participation. This means they will continue to receive information regarding their diagnosis, treatments and ongoing health needs from their provider (no access to website).

Individuals randomly assigned to the treatment group will receive access to UMFollowUp, a secure, HIPAA-compliant website.

All participants will be asked to complete paper-and-pencil surveys at baseline and 9 months later to determine the impact of the web-based intervention.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • History of diagnosis of hematologic malignancy or malignant neoplasm, and in disease free remission at time of recruitment.
  • Must be English-speaking and have access to a computer with internet access, and must have completed treatment at University of Minnesota Medical Center-Fairview for cancer.

Exclusion criteria

  • Individual with significant visual impairments and neurologic/cognitive difficulties which limit their ability to see and under our outcome questionnaires or website content will be excluded from participation.

Treatment and study plan

UMFollowUp

Behavioral

Web-based internet resource for self-reported treatment summaries and psychosocial and physical well-being.

Standard of care

Other

Patients will receive information regarding their diagnosis, treatments, and ongoing health needs from their provider, but will not be provided access to the website.

Primary outcomes

  1. Cancer Knowledge Survey

    Time frame: Time of Enrollment and 9 Months Later

    Measure of patient reported knowledge of their cancer diagnosis, history and treatments.

Secondary outcomes

  1. SF-36 Questionnaire

    Time frame: Time of Enrollment and 9 Months Later

    A measure of quality of life.

  2. Cancer Rehabilitation Evaluation System

    Time frame: Time of Enrollment and 9 Months Later

    Short Form (SF) Medical Interaction Subscale

  3. Herth Hope Index

    Time frame: Time of Enrollment and 9 Months Later

    A measure of self-reported hope.

  4. Multidimensional Scale of Perceived Social Support

    Time frame: Time of Enrollment and 9 Months Later

    A measure of self-reported social support.

  5. Health Locus of Control Scale

    Time frame: Time of Enrollment and 9 Months Later

    A measure of self-reported locus of control.

  6. State Trait Anxiety Inventory

    Time frame: Time of Enrollment and 9 Months Later

    A measure of self-reported anxiety.

Sponsors and collaborators

Lead sponsor

Masonic Cancer Center, University of Minnesota

Other

Registry information

Important dates

Study start
2007
Primary completion
2012
Study completion
2012
First posted
May 8, 2012
Registry last updated
Dec 2, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.